검색
검색 팝업 닫기

Advanced search

Article

Split Viewer

J Chest Surg 2024; 57(5): 458-459

Published online September 5, 2024 https://doi.org/10.5090/jcs.24.061

Copyright © Journal of Chest Surgery.

Commentary: Comparative Study of Indocyanine Green Intravenous Injection and the Inflation-Deflation Method for Assessing Resection Margins in Segmentectomy for Lung Cancer: A Single-Center Retrospective Study

Chang Young Lee , M.D., Ph.D.

Department of Thoracic and Cardiovascular Surgery, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea

Correspondence to:Chang Young Lee
Tel 82-2-2228-2141
Fax 82-2-393-6012
E-mail cyleecs@yuhs.ac
ORCID
https://orcid.org/0000-0002-2404-9357

Received: June 10, 2024; Accepted: June 10, 2024

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked Article: J Chest Surg. 2024;57(5):450-457 https://doi.org/10.5090/jcs.24.008

Recent findings from the JCOG0802 and CALGB alliance randomized control trials have demonstrated favorable short-term and long-term outcomes for segmentectomy in patients with peripheral, early-stage non-small cell lung cancer measuring 2 cm or less [1,2]. This evidence has increased interest in the procedure, which is considered technically more demanding than lobectomy. One of the primary technical challenges is identifying the intersegmental plane (ISP) during minimally invasive surgery.

The study by Bae et al. [3] compared the perioperative outcomes and resection margins of 2 methods used in segmentectomy for lung cancer: indocyanine green (ICG) intravenous injection and the inflation-deflation (ID) method. This retrospective analysis evaluated the effectiveness and safety of these approaches in 319 patients who underwent segmentectomy for clinical stage I lung cancer. The results showed no significant differences in resection margins, specifically bronchial and parenchymal margins, between the ICG and ID methods. Additionally, the length of hospital stay and complication rates were similar between both groups. These findings indicate that both the ICG and ID methods are viable for guiding segmentectomy procedures, offering comparable outcomes in terms of resection margins and perioperative factors. This is particularly relevant as the use of segmentectomy increases for early-stage lung cancer, supporting the flexibility of choosing either method based on surgeons’ preferences and patient-specific factors.

While both ID and ICG methods are effective for ISP identification, it is essential to understand the advantages and limitations of each method to maximize their effectiveness. The ID method is straightforward and easy to perform, and it does not require additional specialized equipment, making it a cost-effective option. However, issues with collateral ventilation may lead to less distinct boundaries between the inflated and deflated segments. In some patients, particularly those with compromised lung function, visualizing the ISP may be challenging, potentially resulting in longer operation times. Conversely, the ICG method provides clear, real-time visualization of the ISP using fluorescence imaging, which can potentially shorten surgery time by making the ISP more easily identifiable without interrupting the surgery. However, the ICG method requires additional equipment and ICG dye, which can increase the overall cost of the procedure.

It is important to master both methods for identifying the ISP; however, it is even more crucial to understand the tumor’s location and the precise anatomical structures involved [4]. Consequently, the European Society of Thoracic Surgeons guidelines strongly recommend preoperative 3-dimensional reconstruction in most cases to define the tumor’s location more accurately, identify potential anatomic vascular variants, and ensure adequate surgical margins.

Although this study has limitations, including its retrospective, single-center design and limited long-term outcomes, it significantly contributes to the field of thoracic surgery. It provides evidence that both ICG and ID methods are effective for achieving intraoperative margins during minimally invasive segmentectomy.

Author contributions

All the work was done by Chang Young Lee.

Conflict of interest

No potential conflict of interest relevant to this article was reported.

Funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

  1. Saji H, Okada M, Tsuboi M, et al. Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial. Lancet 2022;399:1607-17. https://doi.org/10.1016/S0140-6736(21)02333-3.
    Pubmed CrossRef
  2. Altorki N, Wang X, Kozono D, et al. Lobar or sublobar resection for peripheral stage IA non-small-cell lung cancer. N Engl J Med 2023;388:489-98. https://doi.org/10.1056/NEJMoa2212083.
    Pubmed KoreaMed CrossRef
  3. Bae SY, Yun T, Park JH, et al. Comparative study of indocyanine green intravenous injection and the inflation-deflation method for assessing resection margins in segmentectomy for lung cancer: a single-center retrospective study. J Chest Surg 2024 Apr 23. [Epub]. https://doi.org/10.5090/jcs.24.008.
    Pubmed CrossRef
  4. Brunelli A, Decaluwe H, Gonzalez M, et al. European Society of Thoracic Surgeons expert consensus recommendations on technical standards of segmentectomy for primary lung cancer. Eur J Cardiothorac Surg 2023;63:ezad224. https://doi.org/10.1093/ejcts/ezad224.
    Pubmed CrossRef

Article

Commentary

J Chest Surg 2024; 57(5): 458-459

Published online September 5, 2024 https://doi.org/10.5090/jcs.24.061

Copyright © Journal of Chest Surgery.

Commentary: Comparative Study of Indocyanine Green Intravenous Injection and the Inflation-Deflation Method for Assessing Resection Margins in Segmentectomy for Lung Cancer: A Single-Center Retrospective Study

Chang Young Lee , M.D., Ph.D.

Department of Thoracic and Cardiovascular Surgery, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea

Correspondence to:Chang Young Lee
Tel 82-2-2228-2141
Fax 82-2-393-6012
E-mail cyleecs@yuhs.ac
ORCID
https://orcid.org/0000-0002-2404-9357

Received: June 10, 2024; Accepted: June 10, 2024

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked Article: J Chest Surg. 2024;57(5):450-457 https://doi.org/10.5090/jcs.24.008

Body

Recent findings from the JCOG0802 and CALGB alliance randomized control trials have demonstrated favorable short-term and long-term outcomes for segmentectomy in patients with peripheral, early-stage non-small cell lung cancer measuring 2 cm or less [1,2]. This evidence has increased interest in the procedure, which is considered technically more demanding than lobectomy. One of the primary technical challenges is identifying the intersegmental plane (ISP) during minimally invasive surgery.

The study by Bae et al. [3] compared the perioperative outcomes and resection margins of 2 methods used in segmentectomy for lung cancer: indocyanine green (ICG) intravenous injection and the inflation-deflation (ID) method. This retrospective analysis evaluated the effectiveness and safety of these approaches in 319 patients who underwent segmentectomy for clinical stage I lung cancer. The results showed no significant differences in resection margins, specifically bronchial and parenchymal margins, between the ICG and ID methods. Additionally, the length of hospital stay and complication rates were similar between both groups. These findings indicate that both the ICG and ID methods are viable for guiding segmentectomy procedures, offering comparable outcomes in terms of resection margins and perioperative factors. This is particularly relevant as the use of segmentectomy increases for early-stage lung cancer, supporting the flexibility of choosing either method based on surgeons’ preferences and patient-specific factors.

While both ID and ICG methods are effective for ISP identification, it is essential to understand the advantages and limitations of each method to maximize their effectiveness. The ID method is straightforward and easy to perform, and it does not require additional specialized equipment, making it a cost-effective option. However, issues with collateral ventilation may lead to less distinct boundaries between the inflated and deflated segments. In some patients, particularly those with compromised lung function, visualizing the ISP may be challenging, potentially resulting in longer operation times. Conversely, the ICG method provides clear, real-time visualization of the ISP using fluorescence imaging, which can potentially shorten surgery time by making the ISP more easily identifiable without interrupting the surgery. However, the ICG method requires additional equipment and ICG dye, which can increase the overall cost of the procedure.

It is important to master both methods for identifying the ISP; however, it is even more crucial to understand the tumor’s location and the precise anatomical structures involved [4]. Consequently, the European Society of Thoracic Surgeons guidelines strongly recommend preoperative 3-dimensional reconstruction in most cases to define the tumor’s location more accurately, identify potential anatomic vascular variants, and ensure adequate surgical margins.

Although this study has limitations, including its retrospective, single-center design and limited long-term outcomes, it significantly contributes to the field of thoracic surgery. It provides evidence that both ICG and ID methods are effective for achieving intraoperative margins during minimally invasive segmentectomy.

Article information

Author contributions

All the work was done by Chang Young Lee.

Conflict of interest

No potential conflict of interest relevant to this article was reported.

Funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

There is no Figure.

There is no Table.

References

  1. Saji H, Okada M, Tsuboi M, et al. Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial. Lancet 2022;399:1607-17. https://doi.org/10.1016/S0140-6736(21)02333-3.
    Pubmed CrossRef
  2. Altorki N, Wang X, Kozono D, et al. Lobar or sublobar resection for peripheral stage IA non-small-cell lung cancer. N Engl J Med 2023;388:489-98. https://doi.org/10.1056/NEJMoa2212083.
    Pubmed KoreaMed CrossRef
  3. Bae SY, Yun T, Park JH, et al. Comparative study of indocyanine green intravenous injection and the inflation-deflation method for assessing resection margins in segmentectomy for lung cancer: a single-center retrospective study. J Chest Surg 2024 Apr 23. [Epub]. https://doi.org/10.5090/jcs.24.008.
    Pubmed CrossRef
  4. Brunelli A, Decaluwe H, Gonzalez M, et al. European Society of Thoracic Surgeons expert consensus recommendations on technical standards of segmentectomy for primary lung cancer. Eur J Cardiothorac Surg 2023;63:ezad224. https://doi.org/10.1093/ejcts/ezad224.
    Pubmed CrossRef

Stats or Metrics

Share this article on :

  • line